The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cenkos Securities (CNKS): Strong activity and lean cost base

22 Oct 2020 08:00

Edison Investment Research Limited Cenkos Securities (CNKS): Strong activity and lean cost base 22-Oct-2020 / 08:00 GMT/BST


 

London, UK, 22 October 2020

Cenkos Securities (CNKS): Strong activity and lean cost base

Cenkos's first half results demonstrated the benefits of its flexible operating model and strength of its client relationships. While challenges related to COVID-19 are set to continue, Cenkos's focus is on growth companies and its fund-raising year-to-date has had a greater emphasis on corporates financing M&A and growth opportunities rather than for defensive purposes. This should prove more sustainable although, as always, the timing of transactions in the encouraging pipeline reported remains uncertain.

 

Cenkos trades on a price to book multiple of about 1x, well below its 10-year average of 2.2x. Using an ROE/COE model and assuming a cost of equity of 10% and long-term growth of 2% suggests that at the current share price the market assumes a sustainable return of 10.3% for Cenkos. This is ahead of the current relatively subdued level but well below the five-year average of 17%, and is similar to the 11% that could be achieved at the 2019 revenue level once full cost savings are in place and one-off costs fall away.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison: 

Andrew Mitchell, +44 (0)20 3681 2500

Martyn King, +44 (0)20 3077 5745

financials@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-

Twitter  www.twitter.com/Edison_Inv_Res

YouTube  https://www.youtube.com/user/EdisonITV/videos


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1142312 22-Oct-2020 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
4th Apr 20234:35 pmRNSForm 8.3-Sarah Keys & Stephen Keys-Cenkos-Amended
4th Apr 20232:47 pmRNSForm 8.3 - Cenkos Securities
4th Apr 202311:30 amRNSForm 8.3 - Cenkos Securities plc
4th Apr 202310:17 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
4th Apr 202310:05 amRNSForm 8.5 (EPT/NON-RI)
3rd Apr 20233:21 pmRNSForm 8.3(OPD) - N Wells & M-L Wells - Cenkos
3rd Apr 20239:06 amRNSForm 8.5 (EPT/NON-RI)
31st Mar 20236:39 pmRNSForm 8.3 (OPD) Jim Durkin - Cenkos - Amended
31st Mar 20236:23 pmRNSForm 8.3 (OPD) Peter Isard & Nicola Isard - Cenkos
31st Mar 20236:12 pmRNSForm 8.3 - (OPD) Zedra Trust Company - Cenkos
31st Mar 20236:07 pmRNSForm 8.3 - (OPD) Apex Financial Services - Cenkos
31st Mar 20235:42 pmRNSForm 8.3 - (OPD) Cenkos Securities plc
31st Mar 20235:42 pmRNSForm 8.3 - (OPD) Cenkos Securities Plc
31st Mar 20235:23 pmRNSForm 8 (OPD) (Cenkos Securities Plc)
31st Mar 20238:55 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
30th Mar 202310:59 amRNSForm 8.5 (EPT/NON-RI)
29th Mar 20235:21 pmRNSForm 8.3 - CENKOS SECURITIES PLC
29th Mar 20238:46 amRNSForm 8.3 (OPD) Sarah Keys - Cenkos Securities plc
29th Mar 20238:39 amRNSForm 8.5 (EPT/NON-RI)
28th Mar 20231:24 pmRNSForm 8.3 (OPD) Jim Durkin - Cenkos Securities plc
27th Mar 20238:58 amRNSForm 8.5 (EPT/NON-RI)
24th Mar 20232:13 pmRNSForm 8.3 - Cenkos Securities PLC
24th Mar 20231:23 pmGNWForm 8.3 - [Cenkos Securities plc - Opening Declaration - 23 03 2023] - (CGAML)
24th Mar 202310:58 amRNSFurther re Directorate Change
24th Mar 20238:40 amRNSForm 8.5 (EPT/NON-RI)
23rd Mar 20237:01 amRNSRecommended All-Share Merger with finnCap
23rd Mar 20237:00 amRNSRecommended All-Share Merger with Cenkos
21st Mar 202310:40 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20238:56 amRNSForm 8.5 (EPT/NON-RI)
20th Mar 20237:00 amRNSPosting of Annual Report and AGM Notice
16th Mar 20238:45 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202312:55 pmRNSDividend Record and Payment Dates
10th Mar 202310:10 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20237:00 amRNSAnnual Results for the year ended 31 December 2022
9th Mar 20238:48 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20239:09 amRNSForm 8.5 (EPT/NON-RI)
1st Mar 202310:12 amRNSForm 8.5 (EPT/NON-RI)
28th Feb 20239:29 amRNSForm 8.5 (EPT/NON-RI)
27th Feb 20238:39 amRNSForm 8.5 (EPT/NON-RI) - US Solar Fund PLC
24th Feb 20239:09 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202310:42 amRNSForm 8.5 (EPT/NON-RI)
16th Feb 20238:17 amRNSForm 8.5 (EPT/NON-RI)
14th Feb 20238:47 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20239:05 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 20238:33 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202310:15 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20239:16 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20237:00 amRNSTrading Update
7th Feb 20238:32 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 20239:24 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.